Chiasma

📍 Dublin, Ireland👥 21 employees💰 Last funded Nov 2015
Biotechnology Research🌐 amrytpharma.com
Website LinkedIn
Chiasma was acquired by Amryt Pharma on August 5, 2021. Amryt is a biopharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare and orphan diseases. Amryt comprises a growing commercial business and a significant development pipeline. Please Follow us at https://www.linkedin.com/company/amryt-pharma
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Chiasma?
Chiasma has 1 investors on record on gritt.io.
When did Chiasma last raise funding?
The most recent investment in Chiasma recorded on gritt.io was in November 2015.
What industry is Chiasma in?
Chiasma operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Chiasma based?
Chiasma is headquartered in Dublin, Ireland.